| Title : Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics - da Cruz Freire_2022_3.Biotech_12_344 |
| Author(s) : da Cruz Freire JE , Jnior JEM , Pinheiro DP , da Cruz Paiva Lima GE , do Amaral CL , Veras VR , Madeira MP , Freire EBL , Ozrio RG , Fernandes VO , Montenegro A , Montenegro RC , Colares JKB , Jnior RMM |
| Ref : 3 Biotech , 12 :344 , 2022 |
| Abstract : da Cruz Freire_2022_3.Biotech_12_344 |
| ESTHER : da Cruz Freire_2022_3.Biotech_12_344 |
| PubMedSearch : da Cruz Freire_2022_3.Biotech_12_344 |
| PubMedID: 36382241 |
da Cruz Freire JE, Jnior JEM, Pinheiro DP, da Cruz Paiva Lima GE, do Amaral CL, Veras VR, Madeira MP, Freire EBL, Ozrio RG, Fernandes VO, Montenegro A, Montenegro RC, Colares JKB, Jnior RMM (2022)
Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics
3 Biotech
12 :344
da Cruz Freire JE, Jnior JEM, Pinheiro DP, da Cruz Paiva Lima GE, do Amaral CL, Veras VR, Madeira MP, Freire EBL, Ozrio RG, Fernandes VO, Montenegro A, Montenegro RC, Colares JKB, Jnior RMM (2022)
3 Biotech
12 :344